All regulatory communications have data.
Successful communications have a story.

Identify and align with FDA on objectives for key clinical milestones.
Obtain clear direction on FDA concerns and priorities.
Convey clinical program progress with a credible scientific narrative.

That’s where 3D comes in. 3D helps you

• Leverage regulatory precedent and scientific materials to anticipate and proactively address potential FDA concerns.

• Write briefing documents and related submission materials that convey a concise and cohesive scientific story.

• Develop Q&A playbooks that drive discussions to address FDA issues and achieve shared objectives.

We work with you to ensure your FDA interactions are focused and constructive, paving the way for efficient clinical development and clear regulatory objectives.

_{BLA = Biologics License Application; EOP2 = End of Phase 2; IND = Investigational New Drug; NDA = New Drug Application; PMA = Premarket Approval}

Our Latest Thinking

• Taking the “E-A-R-L-Y Train” for Crisis Management
• Active Listening Can Make You a Better Speaker: Part 1
• What Today’s Business Leaders Can Learn from a “Powerless” Woman Who Spoke Her Truth

Regulatory Communications at Your Fingertips

How We Work